| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/30/2004 | EP1173278B1 Metal catalysts and methods for making and using same |
| 06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
| 06/30/2004 | EP0809629B1 2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides |
| 06/30/2004 | CN1509285A Substituted aryl ketons |
| 06/30/2004 | CN1509284A Delta1 pyrrolines |
| 06/30/2004 | CN1509183A Use of proteasome inhibitors to treat dry eye disorders |
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1155566C Process for separating and purifying N-ethyl carbazole |
| 06/29/2004 | US6756500 Subjecting substituted alpha, omega-diene in presence of ruthenium, osmium or molybdenum homogeneous or heterogeneous catalyst to metathesis reaction in presence of ionic liquid to form cyclic compound |
| 06/29/2004 | US6756400 Diaromatic compound containing 2-amine groups, useful for treating neuropathic pain |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756389 Pharmaceutically active compounds and methods of use |
| 06/29/2004 | US6756378 VLA-4 inhibitor compounds |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/24/2004 | WO2004052852A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
| 06/24/2004 | WO2004052851A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 06/24/2004 | WO2004052850A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 06/24/2004 | WO2004052846A1 Tetrahydro-naphthalene derivatives |
| 06/24/2004 | WO2004052845A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 06/24/2004 | WO2004035576A3 Pre-organized tricyclic integrase inhibitor compounds |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122234 Growth Hormone secretagogues |
| 06/24/2004 | US20040122226 Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 06/24/2004 | US20040122064 Enzyme inhibitors of both wild type and mutant variants of HIV reverse transcriptase, particularly resistant varieties; e.g.,N-{4-[(acetylamino)sulfonyl]-2-methylphenyl}-2-[4-chloro-2-(3-cyano-5-methylbenzoyl)phenoxy]acetamide |
| 06/24/2004 | US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 06/24/2004 | US20040122019 4-[4-(2-pyrrolylcarbonyl)-1-piperazinyl]-3-trifluoromethylbenzoylguanidine hydrochloride; treating diseases which inhibit cellular sodium/hydrogen ion exchange |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/24/2004 | US20040121964 For prophylaxis and therapy of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases |
| 06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/24/2004 | DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium |
| 06/24/2004 | DE10258314A1 New alkoxyimino-substituted biphenylcarboxamide derivatives, useful as pesticides, antimicrobials, herbicides and antimycotics, also their new intermediates |
| 06/24/2004 | CA2508788A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
| 06/24/2004 | CA2508619A1 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 06/23/2004 | EP1431286A2 Prodigiosin derivatives for treating cancer or viral diseases |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430032A2 Substituted amides for the treatment of neurological disorders |
| 06/23/2004 | EP1430028A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 06/23/2004 | EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 06/23/2004 | EP1429771A2 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 06/23/2004 | EP1429723A1 Treating effects of excessive reactive oxygen species |
| 06/23/2004 | EP1429607A1 Delta 1-pyrrolines used as pesticides |
| 06/23/2004 | EP1255753B1 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 06/23/2004 | EP1165508B1 Anticancer calcium channel blockers |
| 06/23/2004 | CN1154695C Composition for manufacturing circuit element and printed circuit board |
| 06/23/2004 | CN1154635C Novel compounds with analgesic effect |
| 06/23/2004 | CN1154634C 2-phenyl-substituted heterocyclic 1,3-keonols as herbicides and pesticides |
| 06/22/2004 | US6753447 Functionalized monomers for synthesis of rubbery polymers |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/22/2004 | US6753346 CETP activity inhibitor |
| 06/17/2004 | WO2004051217A2 Process for synthesis bis-aryl diamidoxime compounds |
| 06/17/2004 | WO2004050654A1 Synthesis of pyrrolidine compound and salt thereof |
| 06/17/2004 | WO2004050653A2 Oxime ester photoinitiators with heteroaromatic groups |
| 06/17/2004 | WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | WO2004050618A2 Crystalline form f of atorvastatin hemi-calcium salt |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | WO2004050084A2 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 06/17/2004 | WO2004050030A2 Anti-sickling agents |
| 06/17/2004 | WO2004050024A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 06/17/2004 | WO2004050022A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/17/2004 | WO2004043463A3 Sulfonamides |
| 06/17/2004 | WO2004037796A3 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | WO2004013282A3 Bis (amino acid) molecular scaffolds |
| 06/17/2004 | US20040116744 Substituted n-phenyl-phenoxy nicotinic acid-(thio)amides and their use as herbicides |
| 06/17/2004 | US20040116707 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040116518 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116505 By administering a pyrrolidone compound such as aniracetam, piracetam, oxiracetam, pramiracetam, nefiracetam, nebracetam, fasoracetam, or levetiracetam; Tourette's syndrome, parkinson's disease for example |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116427 Compounds for inhibition of HIV infection by blocking HIV entry |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/17/2004 | CA2508914A1 Modulators of melanocortin receptor |
| 06/17/2004 | CA2508487A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/17/2004 | CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | CA2505893A1 Oxime ester photoinitiators with heteroaromatic groups |
| 06/17/2004 | CA2504742A1 Process for synthesis bis-aryl diamidoxime compounds |
| 06/16/2004 | EP1428821A1 Piperidin-4-yl amines with analgesic effect |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1428533A2 Use of thiazolidine- or pyrrolidine-derivatives of aminoacids as antihyperglycemic agents |
| 06/16/2004 | EP1427722A2 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 06/16/2004 | EP1427702A1 Method for the production of 2-pyrrolidone |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1235777B1 Vitamin d analogues |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1504455A Perfluoroalkylanilins |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/16/2004 | CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders |
| 06/15/2004 | US6750353 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline form |
| 06/15/2004 | US6750255 Calcium receptor-active compounds |
| 06/15/2004 | US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/15/2004 | US6750243 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | US6750216 Kappa agonist compounds and pharmaceutical formulations thereof |
| 06/10/2004 | WO2004048395A1 Phosphorescent compound and electroluminescent element including the same |
| 06/10/2004 | WO2004048352A2 2-cyanopyrrolidines and their analogues as dpp-iv inhibitors |